FUJIFILM Europe GmbH presents AMULET as its first DR-based FFDM system at the European congress of Radiology (ECR) which is held from 6 to 10 March in Vienna, Austria. Based on advanced dual layer amorphous selenium (a-Se) DR detector technology and an innovative direct conversion method, the new system will provide exceptional image quality while also offering the opportunity for reduced dose and enhanced workflow efficiency.
Using a unique combination of technologies, Fujifilm’s DR-based Full Field Digital Mammography (FFDM) system will not only provide enhanced image quality but also increased efficiency. Its 50 micron resolution is currently the best resolution for DR-based FFDM imaging and also an exceptionally small pixel pitch for an amorphous selenium direct conversion method. Using direct optical switching technology, image quality is further enhanced with a high signal to noise (S/N) ratio and the highest DQE (detective quantum efficiency) for clearer images with the potential for reduced dose. This system improves workflow by shortening the image capture cycle time, making it one of the most efficient direct conversion flat panel detector to date.
The introduction of this FFDM system will make Fujifilm one of the first women’s health care company to offer both DR and CR FFDM solutions. Already the world leader in FFDM with more than 6,000 systems sold, Fujifilm will now strengthen this leadership position with a choice of high quality FFDM imaging solutions to best meet the specific needs of any breast diagnostic facility and screening center, regardless of size or imaging requirements.
The 18x24cm detector version of Fujifilm’s DR-based FFDM system was recently released for sale in Europe. The availability of the new system with a 24x30cm detector in Europe is anticipated shortly.
FUJIFILM Europe GmbH is a subsidiary of FUJIFILM Corporation, Tokyo, and delivers technology solutions to meet the imaging and information needs of retailers, consumers, professionals and business customers. Fujifilm is a leading provider of diagnostic imaging products and network systems to meet the needs of healthcare facilities today and well into the future. Fujifilm’s Synapse PACS (picture archiving and communications system) provides a seamless solution for managing, storing and distributing images and information throughout the entire healthcare enterprise. Its Web integrated design and hardware-independence provide a technological infrastructure and deployment model that can be expanded in many ways to adapt to evolving technologies.
Fujifilm employs more than 78,000 people worldwide and in the year ended March 31, 2008, had global revenues in excess of 18 billion Euro. The Fujifilm group comprises of 267 subsidiaries and 32 affiliated companies. Approximately 7% of global turnover are invested into Research and Development each year – enabling the development of new and leading-edge products and services to ensure future growth.
Duesseldorf, 25 February 2009